VRAX
Virax Biolabs Group Limited - Ordinary Shares (VRAX)
$88
About Virax Biolabs Group Limited - Ordinary Shares (VRAX)
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Details
Daily high
$2.96
Daily low
$2.71
Price at open
$2.80
52 Week High
$21.75
52 Week Low
$2.50
Market cap
2.2M
Dividend yield
0.00%
Volume
25,817
Avg. volume
897,110
P/E ratio
-.16
Virax Biolabs Group Limited - Ordinary Shares News
Details
Daily high
$2.96
Daily low
$2.71
Price at open
$2.80
52 Week High
$21.75
52 Week Low
$2.50
Market cap
2.2M
Dividend yield
0.00%
Volume
25,817
Avg. volume
897,110
P/E ratio
-.16